Garodia Chemicals board to meet on May 29 to consider FY26 results

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Garodia Chemicals Limited will hold a board meeting on May 29, 2026, to approve audited financial results for the year ended March 31, 2026. The trading window, closed since April 1, 2026, will reopen 48 hours post-results declaration.

powered bylight_fuzz_icon
41238111

*this image is generated using AI for illustrative purposes only.

Garodia Chemicals Limited has announced that its board meeting is scheduled to be held on Friday, May 29, 2026. The meeting will take place at the registered office of the company. The primary agenda for the meeting is to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026.

Agenda for the Meeting

The Board of Directors will discuss the financial performance of the company for the specified period. The approval of the audited financial results is the key item on the agenda.

Trading Window Closure

The company has informed that the trading window has been closed since the closing of trading hours on BSE on April 01, 2026. This closure applies to designated persons and their immediate relatives to ensure compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The window will remain closed until 48 hours after the declaration of the audited financial results.

Event Date Time
Board Meeting May 29, 2026 -
Trading Window Closure April 01, 2026 Closing hours
Financial Year End March 31, 2026 -

The intimation was submitted to BSE Limited on May 25, 2026, by Ravindra Subhash Salunkhe, Managing Director of Garodia Chemicals Limited.

How might Garodia Chemicals Limited's FY2026 financial results compare to industry peers in the specialty chemicals sector, and what growth trajectory could investors expect going forward?

Will the board meeting on May 29, 2026 include any discussions on dividend declarations, capital expenditure plans, or strategic expansions beyond the audited financial results approval?

How could the prolonged trading window closure since April 1, 2026 have impacted liquidity and investor sentiment for Garodia Chemicals' stock on BSE?

like16
dislike

Garodia Chemicals Limited Submits Q4 FY26 Compliance Certificate Under SEBI Regulations

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Garodia Chemicals Limited filed its Q4 FY26 compliance certificate under SEBI Regulation 74(5) on April 15, 2026, confirming proper dematerialization processes for the quarter ended March 31, 2026. The submission, signed by Managing Director Ravindra Subhash Salunkhe, was supported by MUFG Intime India Private Limited's confirmation certificate and copied to both major Indian depositories.

powered bylight_fuzz_icon
37797794

*this image is generated using AI for illustrative purposes only.

Garodia Chemicals Limited has submitted its quarterly compliance certificate to the Bombay Stock Exchange under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2026. The filing, dated April 15, 2026, demonstrates the company's adherence to regulatory requirements for securities dematerialization processes.

Regulatory Compliance Details

The compliance certificate was filed pursuant to Regulation 74(5) of the SEBI regulations, with Managing Director Ravindra Subhash Salunkhe (DIN: 06753149) signing the submission. The certificate confirms three key compliance areas for the reporting period:

Compliance Parameter Status
Securities Dematerialization Confirmation Completed within stipulated timeframe
Stock Exchange Listing Verification Securities properly listed on exchanges
Certificate Mutilation and Cancellation Completed with depository name substitution

Registrar Confirmation

MUFG Intime India Private Limited, serving as the company's registrar and transfer agent, provided the supporting confirmation certificate dated April 7, 2026. The certificate was issued by Ashok Shetty, Vice President-Corporate Registry, confirming that all dematerialization processes were handled according to prescribed timelines.

The registrar's confirmation specifically validates that securities received from depository participants during the quarter ended March 31, 2026 were properly processed, with appropriate acceptance or rejection notifications sent to depositories.

Depository Notifications

The compliance filing was copied to both major depositories in India to ensure comprehensive regulatory notification:

  • National Securities Depository Limited (Trade World, Lower Parel, Mumbai)
  • Central Depository Services (India) Limited (Marathon Futurex, Lower Parel, Mumbai)

This filing represents standard quarterly compliance reporting, ensuring transparency in the company's securities handling processes and maintaining regulatory adherence for investor protection.

Will Garodia Chemicals' consistent regulatory compliance help attract institutional investors in the upcoming quarters?

How might the company's strong governance practices position it for potential stock exchange upgrades or index inclusions?

Could this compliance track record facilitate Garodia Chemicals' access to capital markets for future fundraising activities?

like17
dislike

More News on Garodia Chemicals Limited